Hayat Pharmaceutical Industries Co. Experiences Decline in Stock Price

Hayat Pharmaceutical Industries Co., listed on the Amman Stock Exchange, witnessed a decline in its stock price on its latest trading session. The company's closing price fell to 3.00 JD, marking a decrease from its last closing price of 3.02 JD. This decline is considered a significant move in the market. Despite the decline, the stock's average price during the trading period was 3.01 JD, indicating a relatively stable performance.

Key Takeaways:

  • Hayat Pharmaceutical Industries Co. experienced a decline in its stock price, with the closing price falling to 3.00 JD, a decrease from its last closing price of 3.02 JD.
  • The stock opened at 3.03 JD, which was also the high for the session, while the low reached 3.00 JD.
  • The value traded for the day amounted to 11,130 JD, with the number of shares transacted totaling 3,700 across 9 transactions.
  • The best bid price was recorded at 3.00 JD for 435 shares, while the best ask price was 3.03 JD.
  • Over the past 12 months, the stock has seen a low of 2.45 JD and a high of 3.15 JD.
  • The company has a price-to-earnings ratio of 9.48 and a dividend yield of 7.33.
  • Listed under the pharmaceutical and medical industries subcategory, Hayat Pharmaceutical Industries continues to be a notable entity within the industrial sector of the Amman Stock Exchange.

Statistics:

  • Closing price: 3.00 JD
  • Last closing price: 3.02 JD
  • Opening price: 3.03 JD
  • High price: 3.03 JD
  • Low price: 3.00 JD
  • Value traded: 11,130 JD
  • Number of shares transacted: 3,700
  • Number of transactions: 9
  • Best bid price: 3.00 JD
  • Best ask price: 3.03 JD
  • Price-to-earnings ratio: 9.48
  • Dividend yield: 7.33
  • 12-month low: 2.45 JD
  • 12-month high: 3.15 JD

Sources:

  • [1] Amman Stock Exchange, Report from 24 Aug 2025.
  • [2] Hayat Pharmaceutical Industries Co., Corporate Profile.